Solventum CorporationSOLVNYSE
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank13
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P13
Within normal range
vs 3Y Ago
-1.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -3.83% |
| Q3 2025 | -3.17% |
| Q2 2025 | -2.07% |
| Q1 2025 | -3.02% |
| Q4 2024 | 5.29% |
| Q3 2024 | -1.56% |
| Q2 2024 | -1.54% |
| Q1 2024 | 2.63% |
| Q4 2023 | 5.56% |
| Q3 2023 | -6.74% |
| Q2 2023 | -1.03% |
| Q1 2023 | 4.28% |
| Q4 2022 | 2.19% |
| Q3 2022 | -8.04% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |